Aktiesnakken — Januar 2010
-
solsen, troldmanden bildte mig ind at Genmab kunne gå 50% op på EGFRs resultater, hvad tror du?
-
det er altfor bearish solsen
-
ok så atp har haft mange tidligere....det undrer mig
-
skal de så ikke øge til 10% nu så?
-
nå de 10% var ejerandel og ikke kurspotentiale på egfr...
-
præcis stinker....de skal have flere
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind